Michael Law, Ph.D. Centre for Health Services and Policy Research The University of British Columbia Vancouver, Canada
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025